- Latest week
- 10 Jul 2026
- Close
- 0.005000
- Fair value
- 0.014298
- Next-week expectancy
- Negative 24.61%
ECS Chart Pack
ECS Botanics Holdings Ltd
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, ECS was broadly unchanged, moving from 0.01 to 0.01. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -18.86 and has improved across the 12-week window. Market Dynamics is 0.43 on the latest week. Next-week expectancy is negative at 24.61% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 0.01
- 12-Week Change
- 0.00%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Negative 24.61%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Below
- Relative Strength
- -18.86
- Market Dynamics
- 0.43
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 0.01
- 12-Week Change
- 0.00%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Negative 24.61%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Below
- Relative Strength
- -18.86
- Market Dynamics
- 0.43
Over the latest 12 completed weeks ending 2026-07-10, ECS was broadly unchanged, moving from 0.01 to 0.01. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -18.86 and has improved across the 12-week window. Market Dynamics is 0.43 on the latest week. Next-week expectancy is negative at 24.61% based on similar historical setup states.
Industry Peers
Australia equities in Drug Manufacturers - Specialty & Generic
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| RGT Argent BioPharma Limited | ASX | 10 Jul 2026 | 0.04 | 0.11 | 0.04 | 0.07 | 105.71% |
| IVX Invion Limited | ASX | 10 Jul 2026 | 0.03 | 0.04 | 0.03 | 0.04 | 15.62% |
| LGP Little Green Pharma Ltd | ASX | 10 Jul 2026 | 0.07 | 0.07 | 0.07 | 0.07 | 4.48% |
| IDT IDT Australia Limited | ASX | 10 Jul 2026 | 0.03 | 0.03 | 0.03 | 0.03 | 3.23% |
| AFP AFT Pharmaceuticals Limited | ASX | 10 Jul 2026 | 3.04 | 3.30 | 3.04 | 3.13 | 2.96% |
| VLS Vita Life Sciences Limited | ASX | 10 Jul 2026 | 2.48 | 2.50 | 2.40 | 2.50 | 0.81% |
| BP8 BPH Global Ltd | ASX | 10 Jul 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% |
| EPN Epsilon Healthcare Limited | ASX | 10 Jul 2026 | 0.02 | 0.02 | 0.02 | 0.02 | 0.00% |
| EXL Elixinol Wellness Limited | ASX | 10 Jul 2026 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00% |
| PER PERCHERON FPO [PER] | ASX | 10 Jul 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% |
| VIT Vitura Health Limited | ASX | 10 Jul 2026 | 0.03 | 0.03 | 0.03 | 0.03 | 0.00% |
| MVP Medical Developments International Limited | ASX | 10 Jul 2026 | 0.42 | 0.44 | 0.41 | 0.41 | -2.41% |
| PKP PEAK FPO [PKP] | ASX | 10 Jul 2026 | 0.02 | 0.02 | 0.02 | 0.02 | -5.56% |
| SNT Syntara Limited | ASX | 10 Jul 2026 | 0.03 | 0.03 | 0.02 | 0.02 | -8.00% |
| CAN Cann Group Limited | ASX | 10 Jul 2026 | 0.01 | 0.01 | 0.00 | 0.00 | -10.00% |